Cargando…

Case report: Zanubrutinib-induced dermatological toxicities: A single-center experience and review

Zanubrutinib, a next-generation non-covalent Bruton’s tyrosine kinase (BTK) inhibitor, shows great efficacy in the treatment of B cell malignancies. Some patients may experience a series of side effects after the treatment of zanubrutinib. Grade 4 dermatological toxicities are rare, which present as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lingling, Tang, Jiao, Feng, Jun, Huang, Yongfen, Cheng, Yuexin, Xu, Hao, Miao, Yuqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359098/ https://www.ncbi.nlm.nih.gov/pubmed/35957865 http://dx.doi.org/10.3389/fonc.2022.941633

Ejemplares similares

Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and MECOM mutations
por: Wang, Lingling, et al.
Publicado: (2022)

Atypical nontraumatic chylothorax in a monoclonal IgM elevated nodal marginal zone lymphoma: A case report and review of the literature
por: Wang, Lingling, et al.
Publicado: (2022)

Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case Series
por: Zhang, Yan, et al.
Publicado: (2021)

Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions
por: Wolska-Washer, Anna, et al.
Publicado: (2023)

Targeting Bruton Tyrosine Kinase With Zanubrutinib for Treatment of Vitreoretinal Lymphoma: Report of 3 Cases
por: Wang, Liang, et al.
Publicado: (2021)

Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
por: Yang, Ting-Ting, et al.
Publicado: (2021)

Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers
por: Espinosa, Maria L., et al.
Publicado: (2021)

Gestational Trophoblastic Neoplasia With Urinary System Metastasis: A Single Center Experience
por: Cheng, Hongyan, et al.
Publicado: (2020)

Zanubrutinib: past, present, and future
por: Tam, Constantine S., et al.
Publicado: (2023)

Efficacy of Zanubrutinib in the Treatment of Bing–Neel Syndrome
por: Wong, Jonathan, et al.
Publicado: (2018)

Simultaneous development of zanubrutinib in the USA and China
por: Li, Guanqiao, et al.
Publicado: (2020)

Correction: Zanubrutinib: past, present, and future
por: Tam, Constantine S., et al.
Publicado: (2023)

A novel UHPLC‒MS/MS method for quantitative analysis of zanubrutinib in rat plasma: application to an in vivo interaction study between zanubrutinib and triazole antifungal
por: Tang, Peng-fei, et al.
Publicado: (2023)

Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma
por: Yang, Haiyan, et al.
Publicado: (2022)

Endoscopic resection of upper gastrointestinal lymphangioma: A single-center experience
por: Shi, Ziyu, et al.
Publicado: (2022)

The Clinical and Pathological Characteristics of Refractory Pituitary Adenomas: A Single Center Experience
por: Liu, Xiaohai, et al.
Publicado: (2022)

Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia
por: Tam, Constantine S., et al.
Publicado: (2023)

Zanubrutinib for mantle cell lymphoma, Waldenström’s macroglobulinaemia
Publicado: (2021)

Zanubrutinib in lymphoproliferative disorders: a comprehensive review
por: Muñoz, Javier, et al.
Publicado: (2022)

Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic Leukemia
por: Marcu, Andra, et al.
Publicado: (2020)

Sclerotherapy for Aneurysmal Bone Cyst: A Single-Center Experience
por: Kumar, Deepak, et al.
Publicado: (2021)

Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation
por: Li, Wenqi, et al.
Publicado: (2023)

Clinical Utility of (18)F-PSMA-1007 Positron Emission Tomography/Magnetic Resonance Imaging in Prostate Cancer: A Single-Center Experience
por: Liu, Ao, et al.
Publicado: (2021)

Laparoscopic transduodenal ampullectomy: initial experience from a single center
por: Gao, Pan, et al.
Publicado: (2023)

Clinical and endoscopic features of primary small bowel lymphoma: a single-center experience from mainland China
por: Tian, Feng-Yu, et al.
Publicado: (2023)

Unilateral Subfrontal Approach for Giant Tuberculum Sellae Meningioma: Single Center Experience and Review of the Literature
por: Xiao, Feng, et al.
Publicado: (2021)

PB1922: THE FIRST REPORT OF REAL-WORLD OUTCOMES OF ZANUBRUTINIB MONOTHERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Luo, Jing, et al.
Publicado: (2023)

Prediction Model of Bone Marrow Infiltration in Patients with Malignant Lymphoma Based on Logistic Regression and XGBoost Algorithm
por: Huang, Yongfen, et al.
Publicado: (2022)

Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First
por: Deshpande, Anagha, et al.
Publicado: (2022)

Disseminated fungal infection in a patient receiving zanubrutinib
por: Walsh, Madalyn, et al.
Publicado: (2023)

Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
por: Phillips, Tycel, et al.
Publicado: (2022)

Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study
por: Li, Ping, et al.
Publicado: (2022)

Outcomes and Prognostic Factors of Metastatic Gastric Cancer: A Single-Center Experience
por: Aseafan, Mohamed, et al.
Publicado: (2022)

P1603: EFFICACY AND SAFETY OF BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN ITP
por: Huang, Qiu-Sha, et al.
Publicado: (2023)

Surgical treatment of spinal tenosynovial giant cell tumor: Experience from a single center and literature review
por: Cao, Shiliang, et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Single-Center Experience
por: Wang, Lu, et al.
Publicado: (2020)

Risk Factors of Ureteral Stenosis After Percutaneous Microwave Ablation of Renal Tumor, a Single-Center Experience
por: Wu, Jiapeng, et al.
Publicado: (2020)

Simultaneous integrated boost within the lymphatic drainage system in breast cancer: A single center study on toxicity and oncologic outcome
por: Klusen, Sophie T., et al.
Publicado: (2023)

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies
por: Tam, Constantine S., et al.
Publicado: (2022)

Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience
por: Skelton, William P, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m8p0ncodchg3s73nak220mr06c